Related Experiment Videos
[Cost-effectiveness analysis of extracorporeal lithotripsy]
P Guermani1, F Cauda, F Alladio
1Divisione Ospedaliera di Urologia, Ospedale S. Giovanni Battista e della Città di Torino, Italie.
Summary
Extracorporeal lithotripsy (ECL) offers a cost-effective solution for urinary stones, with lower costs and shorter recovery than surgery. This analysis supports wider adoption of ECL for improved patient outcomes and economic benefits.
Area of Science:
- Urology
- Health Economics
- Medical Technology Assessment
Context:
- The introduction of extracorporeal lithotripsy (ECL) for urinary stone treatment presents new challenges for clinicians and policymakers.
- A specific Italian hospital has utilized the Sonolith 3000 lithotriptor for urinary stone treatment since 1989, providing a case study for analysis.
Purpose:
- To conduct a cost-effectiveness analysis of extracorporeal lithotripsy (ECL) for treating urinary stones.
- To compare the economic viability and clinical outcomes of ECL against traditional surgical interventions.
Summary:
- The overall treatment cost for a simple urinary stone case using ECL is 5,080 FF.
- The cost per successfully treated case ranges from 6,200 FF to 9,500 FF, considering treatment variables.
- Preliminary results suggest ECL is favorable compared to surgery due to lower costs, reduced morbidity, and shorter convalescence.
Impact:
- The findings support the expansion of extracorporeal lithotripsy treatments.
- ECL demonstrates potential for significant cost savings and improved patient recovery in urological care.
- Further clinical data collection is recommended due to the technique's recent implementation.